The ARCAS Study: Auditory Rhythmical Cueing for Gait in Acute Stroke
ARCAS
Feasibility and Acceptability of an Auditory Rhythmical Cueing Intervention Targeting Balance and Gait in Early Rehabilitation (ARCAS)
1 other identifier
observational
12
1 country
1
Brief Summary
Difficulties with walking is a common and distressing problem following stroke and can lead to reduced independence. Research suggests that using an auditory cue, such as a regular beat or pulse, as part of rehabilitation can improve walking. It is also recommended that early rehabilitation following stroke delivers the bestoutcome for patients. Study aim:To determine whether the use of auditory cueing in early stroke rehabilitation is feasible during a balance and gait therapy programme. Study participants: Adults following acute stroke with walking problems. Participants must be able to sit unsupported and stand with assistance of 1 or 2 people. They will be recruited from the acute stroke unit at North Tyneside General Hospital 2 days to 4 weeks following stroke. A total of 12 participants will be recruited. Study setting: Acute stroke unit - North Tyneside General Hospital and participants homes if they are discharged within the study period. Intervention:Participants will receive auditory rhythmical cueing intervention targeting balance and gait for 30 minutes x5 / week for 3 weeks within the physiotherapy gym on the stroke unit or at home if discharged within the intervention period. The 30 minutes will consist of balance exercises and walking practice using auditory cueing with a metronome. Measures:1. What the participants and the therapists think of the intervention will be assessed by questionnaires. The questionnaires contain open and closed questions and have been developed specifically for this study. 2.The stroke survivors trunk control, balance and walking will be assessed before and after the intervention. Study Duration: 12 months Future Plans: This study will be used to inform a larger study testing if the intervention works and how much it costs
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Feb 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2019
CompletedStudy Start
First participant enrolled
February 4, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 8, 2019
CompletedFirst Posted
Study publicly available on registry
March 12, 2021
CompletedMarch 12, 2021
March 1, 2021
4 months
January 9, 2019
March 11, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Participant questionnaire
To seek views of patients on the intervention programme
3 weeks
Therapist questionnaire
To seek views from therapists on the intervention programme
3 weeks
Other Outcomes (3)
Functional Ambulatory category
3 weeks
Trunk Impairment Scale
3 weeks
Trunk ControlTest
3 weeks
Interventions
Auditory rhythmical cueing intervention targeting balance and gait for 30 minutes x5 per week for 3 weeks.
Eligibility Criteria
Adults within 2 days to 3 weeks following acute stroke with residual mobility problems. They must be able to sit unsupported, stand with assistance of 1- 2 people and be able to comply with the intervention programme.
You may qualify if:
- Adults (\> 18 years) following acute stroke (any subtype) with residual mobility problems
- Within 2 days - 4 weeks post-stroke.
- Be able to sit unsupported and stand with assistance of 1 or 2 people
- Able to provide informed consent to participate in the study.
You may not qualify if:
- Unable to follow the intervention due to cognitive or language impairment.
- Other medical problems affecting walking and balance (e.g. Parkinson's Disease, severe osteoarthritis and cardiopulmonary conditions).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
North Tyneside General Hospital
Newcastle upon Tyne, Tyne and Wear, NE29 8NH, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- OTHER
- Target Duration
- 3 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2019
First Posted
March 12, 2021
Study Start
February 4, 2019
Primary Completion
May 31, 2019
Study Completion
August 8, 2019
Last Updated
March 12, 2021
Record last verified: 2021-03